EPRX
Eupraxia Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · CA
$8.40
+12.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-38.3%
Return on equity
-36.0%
Return on assets
-43.0%
Return on invested capital
0.00x
Asset turnover
-$35.9M
Cash from operations
$2.02
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026